In a 117-patient cohort, 35% waited over 60 days for neoadjuvant chemotherapy, most often because of added workup, second opinions or comorbidities.
|Articles|May 12, 2011
Julia Whiteker on the ONS Breast Care SIG's Future Goals
Author(s)Julia Whiteker, MSN, RN
Julia Whiteker on the Oncology Nursing Society Breast Care Special Interest Groups's Future Goals
Advertisement
Julia Whiteker, MSN, RN the Breast Care special interest group (SIG) social media editor discusses the groups future goals concerning social media
Advertisement
Related to this article
Interviews with 15 young women with breast cancer show fertility preservation decisions unfold under time pressure and carry into survivorship.
Lisa Carter-Bawa, PhD, MPH, APRN, explains how nurses can counter lung cancer fatalism by pairing honesty with hope and using teach-back.
Interim AYA-NAV data show most navigation components reached young patients with cancer as designed, though full sessions lagged during treatment.
As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education and atypical infections.
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Care Coordination Faces Neoadjuvant Chemotherapy Delays in MIBC
2
Outpatient Tarlatamab Feasible in Community Oncology, Real-World Data Show
3
Teaching Communication as a Clinical Skill for Breast Cancer Care
4
FDA Approves Amivantamab for Recurrent or Metastatic HNSCC
5